These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 27907849

  • 1. Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy.
    Cheung YT, Chemaitilly W, Mulrooney DA, Brinkman TM, Liu W, Banerjee P, Srivastava D, Pui CH, Robison LL, Hudson MM, Krull KR.
    Psychoneuroendocrinology; 2017 Feb; 76():114-118. PubMed ID: 27907849
    [Abstract] [Full Text] [Related]

  • 2. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W, Cheung YT, Conklin HM, Jacola LM, Srivastava D, Nolan VG, Zhang H, Gurney JG, Huang IC, Robison LL, Pui CH, Hudson MM, Krull KR.
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [Abstract] [Full Text] [Related]

  • 3. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
    Cheung YT, Brinkman TM, Mulrooney DA, Mzayek Y, Liu W, Banerjee P, Panoskaltsis-Mortari A, Srivastava D, Pui CH, Robison LL, Hudson MM, Krull KR.
    Cancer; 2017 Sep 01; 123(17):3410-3419. PubMed ID: 28452142
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM, Krull KR, Pui CH, Pei D, Cheng C, Reddick WE, Conklin HM.
    J Clin Oncol; 2016 Apr 10; 34(11):1239-47. PubMed ID: 26858334
    [Abstract] [Full Text] [Related]

  • 5. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT, Sabin ND, Reddick WE, Bhojwani D, Liu W, Brinkman TM, Glass JO, Hwang SN, Srivastava D, Pui CH, Robison LL, Hudson MM, Krull KR.
    Lancet Haematol; 2016 Oct 10; 3(10):e456-e466. PubMed ID: 27658980
    [Abstract] [Full Text] [Related]

  • 6. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A, Andersson S, Zeller B, Tamnes CK, Fjell AM, Walhovd KB, Westlye LT, Fosså SD, Ruud E.
    Pediatr Blood Cancer; 2016 Jan 10; 63(1):133-8. PubMed ID: 26312396
    [Abstract] [Full Text] [Related]

  • 7. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
    Follin C, Erfurth EM, Johansson A, Lätt J, Sundgren PC, Österberg K, Spulber G, Mannfolk P, Björkman-Burtscher IM.
    Psychoneuroendocrinology; 2016 Nov 10; 73():157-165. PubMed ID: 27498291
    [Abstract] [Full Text] [Related]

  • 8. The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
    Sabin ND, Cheung YT, Reddick WE, Bhojwani D, Liu W, Glass JO, Brinkman TM, Hwang SN, Srivastava D, Pui CH, Robison LL, Hudson MM, Krull KR.
    AJNR Am J Neuroradiol; 2018 Oct 10; 39(10):1919-1925. PubMed ID: 30213807
    [Abstract] [Full Text] [Related]

  • 9. Neurocognitive outcome and associated factors in long-term, adult survivors of childhood acute lymphoblastic leukemia, treated without cranial radiation therapy.
    Egset KS, Stubberud J, Ruud E, Hjort MA, Eilertsen MB, Sund AM, Hjemdal O, Weider S, Reinfjell T.
    J Int Neuropsychol Soc; 2024 Jul 10; 30(6):523-532. PubMed ID: 38465668
    [Abstract] [Full Text] [Related]

  • 10. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ, Winqvist S, Lanning M, Bloigu R, Harila-Saari AH.
    Pediatr Blood Cancer; 2009 Aug 10; 53(2):156-61. PubMed ID: 19405135
    [Abstract] [Full Text] [Related]

  • 11. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
    Cheung YT, Edelmann MN, Mulrooney DA, Green DM, Chemaitilly W, John N, Robison LL, Hudson MM, Krull KR.
    Cancer Epidemiol Biomarkers Prev; 2016 Aug 10; 25(8):1259-67. PubMed ID: 27345588
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
    Buizer AI, de Sonneville LM, van den Heuvel-Eibrink MM, Veerman AJ.
    Pediatr Blood Cancer; 2005 Sep 10; 45(3):281-90. PubMed ID: 15806539
    [Abstract] [Full Text] [Related]

  • 13. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature.
    Buizer AI, de Sonneville LM, Veerman AJ.
    Pediatr Blood Cancer; 2009 Apr 10; 52(4):447-54. PubMed ID: 19061221
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
    Krull KR, Cheung YT, Liu W, Fellah S, Reddick WE, Brinkman TM, Kimberg C, Ogg R, Srivastava D, Pui CH, Robison LL, Hudson MM.
    J Clin Oncol; 2016 Aug 01; 34(22):2644-53. PubMed ID: 27269941
    [Abstract] [Full Text] [Related]

  • 15. Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.
    Reddick WE, Shan ZY, Glass JO, Helton S, Xiong X, Wu S, Bonner MJ, Howard SC, Christensen R, Khan RB, Pui CH, Mulhern RK.
    Cancer; 2006 Feb 15; 106(4):941-9. PubMed ID: 16411228
    [Abstract] [Full Text] [Related]

  • 16. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.
    Krull KR, Bhojwani D, Conklin HM, Pei D, Cheng C, Reddick WE, Sandlund JT, Pui CH.
    J Clin Oncol; 2013 Jun 10; 31(17):2182-8. PubMed ID: 23650422
    [Abstract] [Full Text] [Related]

  • 17. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors.
    Chiou SS, Lin PC, Liao YM, Yang P.
    Kaohsiung J Med Sci; 2019 Jun 10; 35(6):373-378. PubMed ID: 30913362
    [Abstract] [Full Text] [Related]

  • 18. Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7-40 years after diagnosis.
    Wilberg P, Kanellopoulos A, Ruud E, Hjermstad MJ, Fosså SD, Herlofson BB.
    Support Care Cancer; 2016 Apr 10; 24(4):1497-506. PubMed ID: 26361760
    [Abstract] [Full Text] [Related]

  • 19. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.
    Brace KM, Lee WW, Cole PD, Sussman ES.
    J Clin Exp Neuropsychol; 2019 Oct 10; 41(8):814-831. PubMed ID: 31156064
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.
    Reddick WE, Taghipour DJ, Glass JO, Ashford J, Xiong X, Wu S, Bonner M, Khan RB, Conklin HM.
    Pediatr Blood Cancer; 2014 Jun 10; 61(6):1074-9. PubMed ID: 24464947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.